Quaker Str News Today

A new review paper was published in Oncotarget's Volume 14 on December 12, 2023, entitled, “Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in Brazil: Balancing efficacy, safety, and tolerability.”Credit: 2023 Xavier et al. A new review paper was published in

<p>On December 1, 2023, a new research paper was published in <a href="https://www.oncotarget.com/"><em><u>Oncotarget</u></em></a><em>, </em>entitled, “<a href="https://doi.org/10.18632/oncotarget.28540"><u>Osteopontin induces mitochondrial biogenesis in deadherent cancer cells</u></a>.”</p>

On June 21, 2023, a new research paper was published in Oncotarget, entitled, “Diphenyl ditelluride anticancer activity and DNA topoisomerase I poisoning in human colon cancer HCT116 cells.”

On June 12, 2023, a new review was published in Oncotarget, entitled, “ACSL4: biomarker, mediator and target in quadruple negative breast cancer.”

On May 19, 2023, a new research perspective was published in Oncotarget, entitled, “Targeting the Src N-terminal regulatory element in cancer.”

On May 11, 2023, a new editorial paper was published in Oncoscience, entitled, “UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?”

On May 19, 2023, a new research paper was published in Oncotarget, entitled, “G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis.”

On May 4, 2023, a new research perspective was published in Oncotarget, entitled, “Targeting cellular respiration as a therapeutic strategy in glioblastoma.”

On April 26, 2023, a new review paper was published in Oncotarget, entitled, “Systemic AL amyloidosis: current approach and future direction.”